The undersigned organizations write to request that accountable care organizations (ACOs) are held harmless from anomalous Medicare spending outside their control, such as the aberrant billing for catheters experienced in 2023.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
April 29, 2024
April 29, 2024
The American Hospital Association comments on the discussion draft of the Hospital Inpatient Services Modernization Act to extend the acute care hospital-at-home program.
AHA comments on CMS’ proposals to strengthen the agency’s oversight of accrediting organizations.
The AHA voices support of the Telehealth Modernization Act (H.R. 7623).
The American Hospital Association (AHA) writes regarding a recent The New York Times investigation into the disturbing incentives for data analytics firm, MultiPlan, and large commercial insurers like UnitedHealthcare, Aetna and Cigna, to cut reimbursement rates for care provided to employees of companies with self-funded employer insurance plans and increase costs for patients receiving that care.
AHA addresses UnitedHealthcare’s implementation of its Molecular Pathology Reimbursement Policy on April 1, 2024.
AHA welcomes the opportunity to provide feedback on the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of (SUSTAIN) 340B Act bipartisan discussion draft and accompanying request for information on the critically important 340B Drug Pricing Program.